Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Corrective Spinal Surgery for Severe Spinal Curvature in People With Ankylosing Spondylitis

10 de noviembre de 2026 actualizado por: Qingwen Tao, China-Japan Friendship Hospital

Study on the Efficacy Evaluation of AS Surgical Intervention and the Correlation Between Imaging Sagittal Plane Parameters and Disease Activity

This study is an exploratory self-controlled trial, aiming to preliminarily evaluate the effectiveness and safety of surgical treatment for ankylosing spondylitis.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Estimado)

35

Fase

  • No aplica

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Age ≥18 years.
  • AS confirmed by a rheumatologist using the 1984 modified New York criteria: bilateral grade 2-4 or unilateral grade 3-4 radiographic sacroiliitis plus at least one clinical criterion (inflammatory low-back pain and stiffness for >3 months improving with exercise but not rest; restricted lumbar motion in sagittal and frontal planes; or age- and sex-adjusted restriction of chest expansion). A spine surgeon will confirm deformity and surgical eligibility; the diagnostic evidence and assessors will be recorded.
  • Severe structural spinal or spinopelvic deformity associated with AS.
  • Clinically significant impairment of posture, physical function, activities of daily living, or quality of life related to the deformity.
  • A clinical indication for spine-only single-level or two-level PSO with instrumented fusion, determined by the treating spinal surgical team.
  • Ability and willingness to complete the planned clinical, radiographic, and laboratory assessments.
  • Ability to provide written informed consent.

Exclusion Criteria:

  • Active infection, severe osteoporosis considered to preclude safe PSO by the treating team, or another systemic autoimmune disease likely to confound assessment. SpA-associated psoriasis, uveitis, and inflammatory bowel disease are permitted and will be documented, including activity and treatment.
  • Pregnant or lactating women.
  • With severe cardiovascular or cerebrovascular diseases, liver or kidney - Data collection may be affected by mental or language factors.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Otro: Pedicle Subtraction Osteotomy

To estimate changes in function and sagittal alignment at 12 months after pedicle subtraction osteotomy.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Bath Ankylosing Spondylitis Functional Index(BASFI) from baseline to 12 months after surgery (ΔBASFI)
Periodo de tiempo: at baseline, 6 months, and 12 months

on the 0-10 scale. A negative change indicates improved function.

at baseline, 6 months, and 12 months
Change in T1 pelvic angle (TPA) from baseline to 12 months after surgery (ΔTPA)
Periodo de tiempo: at baseline, 6 months, and 12 months

TPA will be measured on the standing lateral full-spine radiograph as the angle between the line connecting the center of the T1 vertebral body to the bicoxofemoral axis and the line connecting the bicoxofemoral axis to the midpoint of the superior endplate of S1. TPA incorporates both global spinal inclination and pelvic retroversion and provides a global measure of sagittal alignment. A negative change indicates improved function.

at baseline, 6 months, and 12 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
the seventh cervical vertebra (C7)-sagittal vertical axis(SVA)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured on a full-length standing lateral radiograph as the horizontal distance from the C7 plumb line to the posterior-superior corner of the S1 endplate. Unit: millimeters (mm)

at baseline, 6 months, and 12 months
spinosacral angle(SSA)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the angle between the C7 plumb line and the sacral endplate line. Unit: degrees (°)

at baseline, 6 months, and 12 months
Sagittal Pelvic Angle(SPA)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the angle between the sacral endplate line and the line connecting the femoral head axis to the C7 plumb line. Unit: degrees (°)

at baseline, 6 months, and 12 months
pelvic incidence(PI)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the angle between the line perpendicular to the sacral endplate at its midpoint and the line from that midpoint to the femoral head axis. Unit: degrees (°)

at baseline, 6 months, and 12 months
pelvic tilt(PT)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the angle between the vertical line and the line from the femoral head axis to the sacral endplate midpoint. Unit: degrees (°)

at baseline, 6 months, and 12 months
sacral slope(SS)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the angle between the sacral endplate line and the horizontal line. Unit: degrees (°)

at baseline, 6 months, and 12 months
Pelvic Incidence(PI)-lumbar lordosis(LL) mismatch
Periodo de tiempo: at baseline, 6 months, and 12 months

Calculated as PI minus LL. Unit: degrees (°)

at baseline, 6 months, and 12 months
global kyphosis(GK)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the angle between the superior endplate of the upper-most tilted vertebra and the inferior endplate of the lower-most tilted vertebra in the kyphotic segment. Unit: degrees (°)

at baseline, 6 months, and 12 months
thoracic kyphosis(TK)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the Cobb angle between the superior endplate of T4 and the inferior endplate of T12. Unit: degrees (°)

at baseline, 6 months, and 12 months
oracolumbar kyphosis(TLK)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the Cobb angle between the superior endplate of T10 and the inferior endplate of L2. Unit: degrees (°)

at baseline, 6 months, and 12 months
lumbar lordosis(LL)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the Cobb angle between the superior endplate of L1 and the superior endplate of S1. Unit: degrees (°)

at baseline, 6 months, and 12 months
Kyphosis apex vertebra
Periodo de tiempo: at baseline, 6 months, and 12 months

Identified as the vertebra at the apex of the maximal kyphotic curve on the lateral radiograph. Unit: vertebral level (e.g.T8, T9)

at baseline, 6 months, and 12 months
Local osteotomy angle
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the angle created at the osteotomy site between the superior and inferior endplates of the resected/adjacent vertebrae on intraoperative or postoperative imaging. Unit: degrees (°)

at baseline, 6 months, and 12 months
the second cervical vertebra(C2)-the seventh cervical vertebra(C7) lordosis.
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the Cobb angle between the inferior endplate of C2 and the inferior endplate of C7. Unit: degrees (°)

at baseline, 6 months, and 12 months
the second cervical vertebra(C2)-the seventh cervical vertebra(C7) sagittal vertical axis(SVA)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the horizontal distance from the C2 plumb line (vertical line from the C2 centroid) to the posterior-superior corner of C7. Unit: millimeters (mm)

at baseline, 6 months, and 12 months
the first thoracic vertebra(T1) slope
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the angle between the superior endplate of T1 and the horizontal line. Unit: degrees (°)

at baseline, 6 months, and 12 months
the first thoracic vertebra(T1) angle
Periodo de tiempo: at baseline, 6 months, and 12 months

T1 angle measured between the T1 endplate line and the line from the T1 centroid to the C7 centroid. Unit: degrees (°)

at baseline, 6 months, and 12 months
Neck tilt
Periodo de tiempo: at baseline, 6 months, and 12 months

Neck tilt measured as the angle between the vertical line and the line from the sternal notch to the T1 centroid

at baseline, 6 months, and 12 months
Coronal Cobb angle
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the Cobb angle between the superior endplate of the upper-end vertebra and the inferior endplate of the lower-end vertebra of the coronal curve. Unit: degrees (°)

at baseline, 6 months, and 12 months
Coronal vertical axis
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the horizontal distance from the C7 plumb line to the sacral midline (center of S1). Unit: millimeters (mm)

at baseline, 6 months, and 12 months
Pelvic tilt in the coronal plane
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the angle between the horizontal line and the line connecting the bilateral femoral head centers (or the sacral endplate line) on the AP radiograph. Unit: degrees (°)

at baseline, 6 months, and 12 months
proximal junctional kyphosis(PJK)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured as the angle between the inferior endplate of the upper instrumented vertebra (UIV) and the superior endplate of the vertebra two levels above the UIV (UIV+2). Unit: degrees (°)

at baseline, 6 months, and 12 months
proximal junctional failure(PJF)
Periodo de tiempo: at baseline, 6 months, and 12 months

Defined by the presence of proximal junctional fracture, implant failure, or revision surgery at the proximal junction. Unit: event (yes/no)

at baseline, 6 months, and 12 months
Implant failure
Periodo de tiempo: at baseline, 6 months, and 12 months

Defined as radiographic evidence of screw/rod breakage, loosening, or pullout. Unit: event (yes/no)

at baseline, 6 months, and 12 months
surgical safety outcomes
Periodo de tiempo: at baseline, 6 months, and 12 months

Recorded as events (yes/no) or continuous measures during the perioperative and follow-up periods, including but not limited to: intraoperative blood loss (mL), operative time (min), length of hospital stay (d), transfusion rate, surgical site/deep infection rate, neurologic deficit, dural tear, deep vein thrombosis/pulmonary embolism, implant failure, revision surgery rate, readmission rate, and mortality. Units: mL / min / d / event (yes/no) / proportion (%). Lower event incidence, less blood loss, and shorter operative time and hospital stay indicate better safety; the converse indicates worse safety. Serious complications (infection, neurologic deficit, implant failure, revision, death) indicate worse safety.

at baseline, 6 months, and 12 months
Ankylosing Spondylitis Disease Activity Score based on C-reactive protein(ASDAS-CRP)
Periodo de tiempo: at baseline, 6 months, and 12 months

Composite score calculated from four patient-reported items (back pain, duration of morning stiffness, patient global assessment, peripheral joint pain/swelling) and serum CRP using a weighted formula. Minimum = 0; maximum = no fixed upper limit (typically ~0-6; theoretical minimum 0). Higher scores indicate worse disease activity; lower scores indicate better disease activity. Cut-offs: < 1.3 = inactive disease, < 2.1 = low disease activity, > 2.1 = high disease activity.

at baseline, 6 months, and 12 months
C-reactive protein(CRP)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured in peripheral venous blood as serum CRP concentration. Minimum = 0 (cannot be negative); maximum = no fixed upper limit (assay-dependent). Unit: mg/L (or mg/dL). Higher concentrations indicate greater systemic inflammatory burden (worse); lower concentrations indicate less inflammation (better). Normal reference is typically < 5 mg/L (some laboratories < 3 mg/L).

at baseline, 6 months, and 12 months
Erythrocyte Sedimentation Rate(ESR)
Periodo de tiempo: at baseline, 6 months, and 12 months

Measured in peripheral venous blood by the Westergren method as the distance erythrocytes fall at the end of 1 hour. Minimum = 0; maximum = no fixed upper limit (assay-dependent). Unit: mm/h (millimeters per hour). Higher values indicate greater inflammatory activity (worse); lower values indicate better status. Reference ranges are age/sex-specific (e.g., < 15 mm/h in men, < 20 mm/h in women).

at baseline, 6 months, and 12 months
Bath Ankylosing Spondylitis Disease Activity Index(BASDAI)
Periodo de tiempo: at baseline, 6 months, and 12 months

Derived from six patient-reported items (fatigue, neck/back/hip pain, peripheral joint pain/swelling, enthesitis, severity of morning stiffness, duration of morning stiffness), each scored on a 0-10 numeric rating/visual analogue scale; total = mean of the six items. Minimum = 0; maximum = 10. Unit: 0-10 score (unitless). Higher scores indicate worse disease activity; lower scores indicate better disease activity. Cut-off: < 4 = low disease activity/well controlled; ≥ 4 = active disease.

at baseline, 6 months, and 12 months
36-Item Short Form Health Survey(SF-36)
Periodo de tiempo: at baseline, 6 months, and 12 months

Thirty-six patient-reported items yield eight domains (Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional, Mental Health) and two summary scores (Physical Component Summary [PCS] and Mental Component Summary [MCS]). All domains and summary scores are linearly transformed to a 0-100 scale; minimum = 0, maximum = 100. Unit: 0-100 score (unitless). Higher scores indicate better health-related quality of life; lower scores indicate worse.

at baseline, 6 months, and 12 months
Visual Analogue Scale for Pain(VAS)
Periodo de tiempo: at baseline, 6 months, and 12 months

The patient marks current status on a 100-mm (or 0-10) horizontal/vertical line; the distance from the "none" anchor to the mark is measured. Minimum = 0; maximum = 100 mm (or 0-10). Unit: mm (or 0-10 score, unitless). In ankylosing spondylitis studies, pain VAS (e.g., back pain over the past week) and patient global assessment VAS (e.g., overall disease status over the past week) are typically measured separately and should be reported as distinct constructs. Higher scores indicate worse pain/overall status; lower scores indicate better status.

at baseline, 6 months, and 12 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

30 de octubre de 2026

Finalización primaria (Estimado)

1 de julio de 2028

Finalización del estudio (Estimado)

1 de julio de 2029

Fechas de registro del estudio

Enviado por primera vez

29 de octubre de 2026

Primero enviado que cumplió con los criterios de control de calidad

10 de noviembre de 2026

Publicado por primera vez (Actual)

12 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

12 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2025-KY-458-41

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .